Phase 3 randomized controlled trial evaluates photon and proton radiotherapy for brain tumors, suggesting implications for functional survival.
The trial has been approved by the Institutional Ethics Committee of Tata Memorial Centre, Mumbai. The trial has been registered with the Clinical Trial Registry of India (CTRI/2025/03/082568) and Clinicaltrials.gov (study identifier NCT06831461).
No takes yet. Share an insight, caveat, or question.
Dasgupta et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: